Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing.

by Selene M Virk, Richard M Gibson, Miguel E Quinones-Mateu, Jill S Barnholtz-Sloan
Published 2015-01-01

Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy.

by Richard M Gibson, Jan Weber, Dane Winner, Michael D Miller, Miguel E Quiñones-Mateu
Published 2014-01-01

Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand...

by Jan Weber, Justine D Rose, Ana C Vazquez, Dane Winner, Nicolas Margot, Damian J McColl, Michael D Miller, Miguel E Quiñones-Mateu
Published 2013-01-01

Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity

by Angélica Cruz-Lebrón, Ramona Johnson, Claire Mazahery, Zach Troyer, Samira Joussef-Piña, Miguel E. Quiñones-Mateu, Christopher M Strauch, Stanley L. Hazen, Alan D. Levine
Published 2021-01-01

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.

by John Archer, Jan Weber, Kenneth Henry, Dane Winner, Richard Gibson, Lawrence Lee, Ellen Paxinos, Eric J Arts, David L Robertson, Larry Mimms, Miguel E Quiñones-Mateu
Published 2012-01-01

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

by Art F. Y. Poon, Emmanuel Ndashimye, Mariano Avino, Richard Gibson, Cissy Kityo, Fred Kyeyune, Immaculate Nankya, Miguel E. Quiñones-Mateu, Eric J. ARTS, The Ugandan Drug Resistance Study Team
Published 2019-01-01

Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay

by Nicholas Silver, Mary Paynter, Georgina McAllister, Maureen Atchley, Christine Sayir, John Short, Dane Winner, David J. Alouani, Freddie H. Sharkey, Kicki Bergefall, Kate Templeton, David Carrington, Miguel E. Quiñones-Mateu
Published 2018-11-01

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries

by Richard M. Gibson, Gabrielle Nickel, Michael Crawford, Fred Kyeyune, Colin Venner, Immaculate Nankya, Eva Nabulime, Emmanuel Ndashimye, Art F. Y. Poon, Robert A. Salata, Cissy Kityo, Peter Mugyenyi, Miguel E. Quiñones-Mateu, Eric J. Arts
Published 2017-12-01

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria

by Nicaise Ndembi, Fati Murtala-Ibrahim, Monday Tola, Jibreel Jumare, Ahmad Aliyu, Peter Alabi, Charles Mensah, Alash’le Abimiku, Miguel E. Quiñones-Mateu, Trevor A. Crowell, Soo-Yon Rhee, Robert W. Shafer, Ravindra Gupta, William Blattner, Manhattan E. Charurat, Patrick Dakum
Published 2020-11-01

Tenth Scientific Biennial Meeting of the Australasian Virology Society—AVS10 2019

by Karla J. Helbig, Rowena A. Bull, Rebecca Ambrose, Michael R. Beard, Helen Blanchard, Till Böcking, Brendon Chua, Agathe M. G. Colmant, Keaton M. Crosse, Damian F. J. Purcell, Johanna Fraser, Joshua A. Hayward, Stuart T. Hamilton, Matloob Husain, Robin MacDiarmid, Jason M. Mackenzie, Gregory W. Moseley, Thi H. O. Nguyen, Miguel E. Quiñones-Mateu, Karl Robinson, Chaturaka Rodrigo, Julio Rodriguez-Andres, Penny A. Rudd, Anja Werno, Peter White, Paul Young, Peter Speck, Merilyn Hibma, Heidi E. Drummer, Gilda Tachedjian
Published 2020-06-01